How much bacopa is in Focus Factor? The 640 mg label, read

How much bacopa is in Focus Factor? The label does not say. Focus Factor Original prints a 640 mg “synergistic and proprietary formulation” per 4-tablet serving, with bacopa whole-herb extract listed third among 16 named components and no dose for any of them. The ceiling is 640 mg for everything in the blend, or 160 mg of blend per tablet.

That is the whole answer to the question as typed, and it is the answer the top-ranking reviews give before stopping. This review keeps going, because the label says more than “not disclosed” once you put it beside the label the brand used to print, and because one of the 16 components carries a footnote the other reviews transcribe without reading.

This desk read three primary documents on 11 September 2026: the Focus Factor Original product page with its Supplement Facts panel and FAQ; the older Focus Factor label the NIH Dietary Supplement Label Database holds as record 205938; and FDA’s vinpocetine page. Focus Factor is, per its own footer, a brand of Synergy CHC, which trades on NASDAQ as SNYR. This desk has no physical bottle in hand; everything below is what the brand and the database print.

What the current Focus Factor label prints

The panel is in two halves. The first is a conventional multivitamin: vitamins, minerals and choline, each with an amount and a Daily Value. Choline (as choline bitartrate) is disclosed at 30 mg, on its own line, outside the blend. That matters later.

The second half is the line the query is really about: “Synergistic and proprietary formulation 640 mg”, followed by a run-on list. In the order the label prints them: dimethylaminoethanol (as DMAE bitartrate), L-glutamine, bacopa (whole herb) extract, L-pyroglutamic acid, phosphatidylserine, docosahexaenoic acid concentrate (15 percent DHA, from anchovy, sardine and salmon body oil), inositol, N-acetyl tyrosine, bilberry fruit standardised extract (25 percent anthocyanosides), gamma-aminobutyric acid, grape whole-fruit extract and Activin grape seed extract, vinpocetine with a dagger, sodium chloride, huperzine A (from toothed clubmoss whole-herb extract), boron (as boron citrate) and vanadium (as vanadyl sulfate).

Sixteen named lines, one number. The bacopa is not a branded extract on this label and carries no standardisation figure, so even a reader who guessed a milligram amount would not know what fraction of it was bacosides.

The dagger on vinpocetine resolves, at the foot of the panel, to this sentence: “Not recommended for use by pregnant women or women of childbearing age.” A second, softer version appears above the footer: the Original formula “is not recommended for use by pregnant women or women who may become pregnant.” Neither of the two 2026 review pages this desk’s search read prints that text, and the third page was fact-checked in January 2017, before the warning existed.

How much bacopa is in Focus Factor, as far as arithmetic allows

The label gives one hard number, 640 mg, and the reviews that rank for this query supply the doses they think matter. The Supplement Critique review, fact-checked 22 January 2017, cites bacopa at 300 mg a day for 12 weeks in a 2001 study, phosphatidylserine at 300 mg a day split into three doses, DHA at 1.16 g a day for six months in a 2013 study, and vinpocetine at 5 to 10 mg in a 1987 study. This desk did not read those trials; PubMed refused a plain fetch in this run. Treat the figures as the doses the reviews cite, not as this desk’s finding, and the arithmetic below as an illustration of what 640 mg can hold rather than a claim about what it does hold.

Read the table as a set of constraints, not a formula. Bacopa at the dose the reviews cite would fit, but only by starving almost everything else. Bacopa and phosphatidylserine both at their cited doses would leave the remaining fourteen ingredients sharing 40 mg, which is less than a single decorative line on most panels. And the DHA row is the one no arithmetic rescues: the label says the concentrate is 15 percent DHA, so even a blend that was nothing but fish-oil concentrate would deliver 96 mg of DHA, against a cited study dose of 1,160 mg.

None of this tells you the bacopa dose. It tells you that the 16 components cannot all be present at the amounts the ingredient literature the reviews lean on describes, and that the label was written so a reader cannot say which ones are.

What changed between the 692 mg label and the 640 mg one

The 2017 incumbent describes a 692 mg proprietary formula with choline and something called Trace-Lyte inside it. That is not the label sold in 2026. The NIH Dietary Supplement Label Database holds a Focus Factor label under the brand name FOCUSfactor, distributed by Factor Nutrition Labs, whose trademark statements name Bacopin as a registered trademark of Sabinsa; this desk’s read of that record stopped before its ingredient rows, so the 692 mg weight and the Bacopin, vinpocetine and Trace-Lyte electrolyte concentrate lines inside the blend rest on the 2017 review’s description. The database’s own event log for that record reads “Off Market” dated 13 March 2019 and “Date entered into DSLD” dated 23 August 2019; this desk reports both dates as printed and draws no reformulation date from them.

Read charitably, the label got better in two small ways. Choline came out of the blend and onto a disclosed line, so one of the older label’s mystery components now has a number, even if 30 mg is a modest one. And the pregnancy line hardened from “consult a physician” to “not recommended”. Read less charitably, the blend lost 52 mg, gained nothing a buyer can measure, and swapped a branded, trademark-registered bacopa for an unbranded one. The bacopa question is exactly as unanswerable on the new label as on the old.

This is the pattern the category keeps showing: brands revise around a proprietary blend without ever opening it. For contrast, Beyond Raw’s Nootropic prints Synapsa bacopa at 320 mg standardised to 160 mg bacosides, which is the sentence this review cannot write about Focus Factor, and Profound Focus publishes all seven of its doses. A printed milligram is a claim you can argue with. A blend total is a claim you can only shrug at.

Why is there a dagger on vinpocetine?

Because of FDA, though the label does not say so. FDA’s vinpocetine page, read on 11 September 2026, states that vinpocetine is a synthetic compound derived from vincamine or tabersonine and is not a constituent of any plant, and that FDA has not evaluated whether it is effective for any of the uses it is marketed for, memory and focus included.

Two dated actions sit on that page. On 6 September 2016 FDA published a Federal Register notice seeking comment on its tentative conclusions that vinpocetine does not meet the definition of a dietary ingredient and is excluded from the definition of a dietary supplement, because it had been authorised for investigation as a new drug before it was marketed as a supplement (Docket FDA-2016-N-2523). On 3 June 2019 FDA issued a safety warning for women of childbearing age, saying that data it reviewed associates vinpocetine with adverse reproductive effects, that it may cause a miscarriage or harm fetal development, and advising pregnant women and women who could become pregnant not to take it. The same warning advised firms selling vinpocetine products to check that their labels warn against such use.

That last sentence is the dagger’s origin. Focus Factor’s footnote is, word for word in spirit, the warning FDA asked firms to carry. Credit where due: the brand did what the agency advised. What the FDA page read does not record is any final determination on the 2016 tentative conclusions. Vinpocetine is not described there as banned, and this review does not call it that; it is described as an ingredient whose status as a dietary ingredient FDA tentatively doubted in 2016 and has, on the page read, not resolved. FDA’s own regulatory agenda shows how slowly that exclusion machinery moves in either direction.

For the buyer, the practical point is narrower. A label that says “not recommended for women of childbearing age” on an everyday memory tablet is an unusual sentence, and the three reviews read for this query do not print it.

Does Focus Factor actually work?

The only trial the brand cites is its own: the product page says the Focus Factor group’s mean word recall rose by 6.5 words against 4.5 for placebo after six weeks. This desk has not read that study. A brand-run trial of a blend whose doses are secret cannot be checked ingredient by ingredient, so the honest answer is that the label does not let anyone say.

There is a structural reason to be careful with the study even if it is sound. A trial of a 16-component blend plus a multivitamin is a trial of that whole product, at that time, in the people enrolled. Whether it was run on the 692 mg label or the 640 mg one is something this desk cannot tell from the product page, and a two-word difference in recall between arms is a finding about a mixture, not evidence for the bacopa or anything else inside it.

The product page also carries “#1 Pharmacist Recommended Memory Brand”, footnoted to a Pharmacy Times survey of pharmacists’ OTC recommendations for 2025-2026. That is a claim about what pharmacists recommend, which is a fact about pharmacists. It is not a dose.

What are the main active ingredients in Focus Factor?

A vitamin and mineral panel with disclosed amounts, choline at 30 mg, and a 640 mg ‘synergistic and proprietary formulation’ whose 16 named components include DMAE bitartrate, L-glutamine, bacopa whole-herb extract, phosphatidylserine, a 15 percent DHA fish-oil concentrate, GABA, vinpocetine and huperzine A. No individual dose inside the 640 mg is printed.

Which of those is “main” is the question the label declines to answer. DMAE bitartrate is listed first, bacopa third, vinpocetine twelfth, huperzine A fourteenth; the label’s order is the only ranking on offer, and this review makes no claim about what that order means.

How many Focus Factor tablets do you take a day?

The label’s serving is 4 tablets a day with food, and the brand’s FAQ says you can take additional tablets up to a maximum of 8 a day. At 4 tablets the proprietary formulation is 640 mg; at 8 it is 1,280 mg. Doubling the dose doubles every unknown inside the blend, including whatever vinpocetine is present.

The older DSLD record is stricter on paper: it logs the serving as exactly 4 tablets, one serving a day, though its printed directions carry the same “up to a maximum of 8” line. A 150-tablet bottle is 37 days at 4 tablets and under 19 at 8.

Does Focus Factor contain caffeine?

No, according to the brand. The FAQ on the Focus Factor Original product page states that the Original formula does not contain caffeine, and caffeine does not appear anywhere on the Supplement Facts panel this desk read. That makes it a rare stimulant-free product in the focus category, though it says nothing about the other Focus Factor variants.

Is Focus Factor safe to take during pregnancy?

The label itself says not to. The panel puts a dagger on vinpocetine that resolves to ‘Not recommended for use by pregnant women or women of childbearing age’, and the product page repeats that the Original formula is not recommended for pregnant women or women who may become pregnant. That line follows FDA’s June 2019 vinpocetine warning. Ask a clinician, not a label.

Pros and cons

Verdict

The score sits where it does because the question in the title has no answer on the label, and that is the brand’s choice rather than an accident. Focus Factor has revised this panel at least once, moved choline out to a disclosed line, tightened its warning, and left the blend closed. A brand that can print 30 mg of choline can print the bacopa.

It suits somebody who wanted a daily multivitamin and is indifferent to what the extra 640 mg contains. It does not suit anyone buying it for the bacopa, the phosphatidylserine or the DHA, because nobody outside the brand, including the reviews that rank above this one, can tell them how much of any of those they are getting. And on the label’s own wording it does not suit women who are or could become pregnant.

Which is the place to say the plain thing. This is a dietary supplement. Its statements have not been evaluated by the FDA, it is not intended to diagnose, treat, cure or prevent any disease, and a blend total is a fact about the tablet rather than a promise about you. Anyone taking prescription medication, or who is pregnant or planning to be, belongs with a pharmacist or clinician before they belong at the checkout.